If you have an interest in developments in allergy diagnosis and treatments, www.dbv-technologies.com will be right up your street.
Increasing numbers of individuals suffer from one or more allergy. The most common allergies include foods such as egg, milk and peanuts.
DBV Technologies is seemingly well on the way to finding an EPIT-based solution to allergies – more information is available on http://www.dbv-technologies.com/en/epit.
The Viaskin patch is a simple adhesive patch worn on the skin. The essential components of the patch include an electrostatically-charged backing and an adhesive crown.
The principle underlying this epicutaneous patch isn’t particularly complicated. An electrostatically-charged spray of protein compound (the antigen) is sprayed onto the patch’s backing.These antigens or allergens can travel through the skin and into the Langerhans cells, rather than entering the bloodstream, with the attendant risk of anaphylaxis. These cells are very tolerogenic, making them ideal for the purposes of ‘tolerization’.
Patch technology is especially promising in relation to pediatric allergy treatment (http://www.dbv-technologies.com/en/viaskin-products) because it does away with the use of injections.